Hims & Hers Health, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on November 13, 2025, by Hims & Hers Health, Inc. (NYSE: HIMS). The report details a new share repurchase program authorized by the Board of Directors and provides an update on the completion of a prior repurchase program.
Key Financial Metrics and Capital Allocation
- New Repurchase Authorization: The Board approved a new program to repurchase up to $250.0 million of Class A common stock.
- Program Expiration: The new program expires on November 11, 2028.
- Recent Repurchase Activity: Between October 1, 2025, and November 7, 2025, the company repurchased 1,334,572 shares for a total of $55.5 million.
- Prior Program Status: The previous $100.0 million repurchase program (effective July 2024) has been fully utilized.
Material Changes
The primary material change is the authorization of a new $250.0 million share buyback program, replacing the fully utilized prior program. The filing does not provide comparative financial data such as revenue, profit, or cash flow for the period.
Outlook and Management Commentary
Management intends to execute the new repurchase program on a discretionary basis, subject to general business and market conditions and other investment opportunities. Purchases may be made via open market transactions, privately negotiated deals, or Rule 10b5-1 plans. The program may be suspended or discontinued at any time.
Investor Verification Checklist
- Verify the total number of shares outstanding post-repurchase to assess dilution impact.
- Confirm the company's current cash and cash equivalents to evaluate the liquidity impact of the new $250.0 million authorization.
- Review the company's most recent quarterly report (10-Q) for updated revenue and profitability metrics not included in this 8-K.
- Monitor future filings for the actual execution rate of the new repurchase program.